Summary of aromatase inhibitor clinical
✍
Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
English
⚖ 115 KB
Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge